Current Problems in Cardiology最新文献

英文中文

Editor’s Message 编辑器’的消息

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-09-02 DOI: 10.1016/S0146-2806(25)00179-3

引用次数: 0

Guidelines for Authors 作者指南

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-09-02 DOI: 10.1016/S0146-2806(25)00182-3

引用次数: 0

Information for Readers 读者资讯

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-09-02 DOI: 10.1016/S0146-2806(25)00181-1

引用次数: 0

Title Page 标题页

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-09-02 DOI: 10.1016/S0146-2806(25)00178-1

引用次数: 0

The top 100 most cited articles in cardiovascular research: A bibliometric perspective 心血管研究中被引用最多的100篇文章：文献计量学视角

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-25 DOI: 10.1016/j.cpcardiol.2025.103153

Siddig Ibrahim Abdelwahab , Manal Mohamed Elhassan Taha , Abdullah Farasani , Jobran M Moshi , Ahmad Assiri , Saeed Alshahrani , Khaled A Sahli , Hussam M. Shubaily , Waseem Hassan

Objective

The aim is to analyze the citation dynamics, and research focus of the top 100 most cited cardiovascular research.

Methods

Data were retrieved from the Scopus database in January 2025, focusing on journals containing the term “cardio” in their title. Only original research articles and reviews were included. The data were analyzed using VOSviewer and R Studio to assess co-authorship networks, keyword co-occurrence, citation mapping, and citation impact indicators.

Results

A total of 100 articles, published between 1967 and 2020, were included in the analysis. These articles had an average of 2,285 citations each. The growth rate of publications was 3.74 %, with an average document age of 20.8 years. Collaboration was extensive, with 1,653 authors contributing to these papers, and 25 % of publications involved international collaboration. Citation analysis showed increasing citation rates over time, with recent papers achieving significant impact in a short period. The top authors, universities, countries, and sources of publication were identified, revealing the global nature of cardiovascular research and its collaborative nature. The title co-words analysis was also performed to understand the main focus of the most cited papers.

Conclusions

This study offers a deeper understanding of the most cited cardiovascular research papers, addressing gaps in previous bibliometric studies by providing insights into citation dynamics, author collaborations, and thematic shifts. Future studies should explore the quality of research and expand the scope of bibliometric analyses.

目的分析被引频次前100位的心血管科学研究的被引动态及研究热点。方法于2025年1月从Scopus数据库中检索，重点检索标题中包含cardio一词的期刊。仅纳入原创研究文章和综述。使用VOSviewer和R Studio对数据进行分析，评估合著网络、关键词共现、引文映射和引文影响指标。结果共纳入1967 - 2020年间发表的100篇文献。这些文章平均每篇被引用2285次。发文量增长率为3.74%，平均文献年龄为20.8年。合作非常广泛，有1653位作者对这些论文做出了贡献，25%的出版物涉及国际合作。引文分析显示，随着时间的推移，被引率呈上升趋势，近期论文在短时间内产生显著影响。确定了顶级作者、大学、国家和出版物来源，揭示了心血管研究的全球性质及其合作性质。还进行了标题共词分析，以了解被引次数最多的论文的主要焦点。本研究提供了对被引用最多的心血管研究论文的更深入了解，通过提供对引用动态、作者合作和主题变化的见解，解决了以前文献计量学研究中的空白。未来的研究应探索研究的质量，并扩大文献计量分析的范围。

{"title":"The top 100 most cited articles in cardiovascular research: A bibliometric perspective","authors":"Siddig Ibrahim Abdelwahab , Manal Mohamed Elhassan Taha , Abdullah Farasani , Jobran M Moshi , Ahmad Assiri , Saeed Alshahrani , Khaled A Sahli , Hussam M. Shubaily , Waseem Hassan","doi":"10.1016/j.cpcardiol.2025.103153","DOIUrl":"10.1016/j.cpcardiol.2025.103153","url":null,"abstract":"<div><h3>Objective</h3><div>The aim is to analyze the citation dynamics, and research focus of the top 100 most cited cardiovascular research.</div></div><div><h3>Methods</h3><div>Data were retrieved from the Scopus database in January 2025, focusing on journals containing the term “cardio” in their title. Only original research articles and reviews were included. The data were analyzed using VOSviewer and R Studio to assess co-authorship networks, keyword co-occurrence, citation mapping, and citation impact indicators.</div></div><div><h3>Results</h3><div>A total of 100 articles, published between 1967 and 2020, were included in the analysis. These articles had an average of 2,285 citations each. The growth rate of publications was 3.74 %, with an average document age of 20.8 years. Collaboration was extensive, with 1,653 authors contributing to these papers, and 25 % of publications involved international collaboration. Citation analysis showed increasing citation rates over time, with recent papers achieving significant impact in a short period. The top authors, universities, countries, and sources of publication were identified, revealing the global nature of cardiovascular research and its collaborative nature. The title co-words analysis was also performed to understand the main focus of the most cited papers.</div></div><div><h3>Conclusions</h3><div>This study offers a deeper understanding of the most cited cardiovascular research papers, addressing gaps in previous bibliometric studies by providing insights into citation dynamics, author collaborations, and thematic shifts. Future studies should explore the quality of research and expand the scope of bibliometric analyses.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 11","pages":"Article 103153"},"PeriodicalIF":3.3,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144933731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trends in cardiovascular risk in Peru: A 10-year population-based analysis (2015–2024) 秘鲁心血管风险趋势：基于人群的10年分析（2015-2024）

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-20 DOI: 10.1016/j.cpcardiol.2025.103155

Carlos Diaz-Arocutipa MD , Natalia Nombera-Aznaran MD , Vicente Benites-Zapata MD , Pedro Kikushima-Alcantara MD , Percy Herrera-Añazco MD

Background

Data on national trends in cardiovascular risk in Latin America are limited. We aimed to evaluate changes in estimated 10-year cardiovascular risk in Peru between 2015 and 2024, and assess disparities by sex, age, residence, and region.

Methods

We conducted a cross-sectional analysis using nationally representative data from the Peruvian Demographic and Health Survey. Adults aged 40–74 years with complete risk factor data were included. Ten-year cardiovascular risk was estimated using the 2019 WHO non-laboratory prediction charts for Andean Latin America. Trends in mean absolute risk and the proportion of individuals at ≥high risk were assessed using joinpoint regression models, overall and by sex, age group, area of residence, and region.

Results

Among 104,617 participants, mean estimated 10-year cardiovascular risk declined from 5% in 2015 to 4.4% in 2024 (average annual percent change [AAPC] −2.3%; 95% C: −3.2 to −1.5). The prevalence of ≥high cardiovascular risk decreased from 10.3% to 8.5% (AAPC −3.2%; 95% CI −5.0 to −1.6). Risk declined significantly among women, younger adults, and both urban and rural populations, but remained unchanged in men and older adults. Regional trends were heterogeneous, with the steepest reductions observed in Amazonas, Ica, and Ayacucho.

Conclusions

Although a slight decline in estimated cardiovascular risk was observed in Peru over the past decade, the change may have limited clinical relevance. These trends emphasize the need for stronger, equity-focused efforts to reduce the burden of cardiovascular disease at the national level.

背景：关于拉丁美洲国家心血管风险趋势的数据有限。我们的目的是评估秘鲁2015年至2024年间10年心血管风险的变化，并评估性别、年龄、居住地和地区的差异。方法采用秘鲁人口与健康调查中具有全国代表性的数据进行横断面分析。年龄在40-74岁之间且有完整危险因素数据的成年人被纳入研究对象。使用2019年世卫组织安第斯拉丁美洲非实验室预测图估计了十年心血管风险。使用联合点回归模型评估总体和按性别、年龄组、居住区域和地区划分的平均绝对风险趋势和≥高风险个体比例。在104,617名参与者中，平均估计10年心血管风险从2015年的5%下降到2024年的4.4%（平均年变化百分比[AAPC] - 2.3%; 95% C: - 3.2至- 1.5）。≥高心血管风险的患病率从10.3%降至8.5% （AAPC为- 3.2%；95% CI为- 5.0至- 1.6）。风险在女性、年轻人以及城市和农村人口中显著下降，但在男性和老年人中保持不变。区域趋势是不均匀的，亚马逊、伊卡和阿亚库乔地区的降幅最大。结论：尽管秘鲁在过去十年中观察到心血管风险估计值略有下降，但这种变化可能具有有限的临床相关性。这些趋势强调需要加强以公平为重点的努力，在国家一级减轻心血管疾病负担。

{"title":"Trends in cardiovascular risk in Peru: A 10-year population-based analysis (2015–2024)","authors":"Carlos Diaz-Arocutipa MD , Natalia Nombera-Aznaran MD , Vicente Benites-Zapata MD , Pedro Kikushima-Alcantara MD , Percy Herrera-Añazco MD","doi":"10.1016/j.cpcardiol.2025.103155","DOIUrl":"10.1016/j.cpcardiol.2025.103155","url":null,"abstract":"<div><h3>Background</h3><div>Data on national trends in cardiovascular risk in Latin America are limited. We aimed to evaluate changes in estimated 10-year cardiovascular risk in Peru between 2015 and 2024, and assess disparities by sex, age, residence, and region.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional analysis using nationally representative data from the Peruvian Demographic and Health Survey. Adults aged 40–74 years with complete risk factor data were included. Ten-year cardiovascular risk was estimated using the 2019 WHO non-laboratory prediction charts for Andean Latin America. Trends in mean absolute risk and the proportion of individuals at ≥high risk were assessed using joinpoint regression models, overall and by sex, age group, area of residence, and region.</div></div><div><h3>Results</h3><div>Among 104,617 participants, mean estimated 10-year cardiovascular risk declined from 5% in 2015 to 4.4% in 2024 (average annual percent change [AAPC] −2.3%; 95% C: −3.2 to −1.5). The prevalence of ≥high cardiovascular risk decreased from 10.3% to 8.5% (AAPC −3.2%; 95% CI −5.0 to −1.6). Risk declined significantly among women, younger adults, and both urban and rural populations, but remained unchanged in men and older adults. Regional trends were heterogeneous, with the steepest reductions observed in Amazonas, Ica, and Ayacucho.</div></div><div><h3>Conclusions</h3><div>Although a slight decline in estimated cardiovascular risk was observed in Peru over the past decade, the change may have limited clinical relevance. These trends emphasize the need for stronger, equity-focused efforts to reduce the burden of cardiovascular disease at the national level.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 10","pages":"Article 103155"},"PeriodicalIF":3.3,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144891900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Interatrial shunt devices in heart failure with preserved ejection fraction: A meta-analysis of randomized trials 房间分流装置用于保留射血分数的心力衰竭：随机试验的荟萃分析。

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-20 DOI: 10.1016/j.cpcardiol.2025.103154

Alonzo Armani Prata , Ana Carolina Covre Coan , Megan Coylewright MD, MPH , Julia Marques Fernandes , Eric Shih Katsuyama MD , Christian Ken Fukunaga , Gabriel Scarpioni Barbosa , Pedro Gabriel Scardini , Gioli-Pereira Luciana MD, PhD

Background

The clinical effect of an iatrogenic interatrial shunt in heart failure with preserved ejection fraction (HFpEF) was based on observational data, wherein decompression of the pressure-overloaded left atrium improved symptoms and hemodynamics. However, the identification of a specific patient population that may benefit remains unclear.

Methods

We searched for randomized controlled trials (RCTs) that compared the creation of interatrial shunts versus a sham procedure in patients with HFpEF. The primary outcomes of interest were HF events and Cardiovascular (CV) mortality.

Results

Three RCTs were included, encompassing 966 patients, of which 479 (49.5%) were in the interatrial shunt group. The mean age of the participants was 73.2 years, with an average LVEF of 58.7%. Of the 479 patients undergoing interatrial shunt placement, 69% had exercise hemodynamics to assist in selection for therapy. Interatrial shunt therapy in the selected patients showed a trend towards an increased risk of HF events (RR:1.29;95%CI:0.98-1.70;p=0.069) and CV death (RR:2.30;95%CI:0.94-5.59;p=0.067), compared with the sham procedure.

Conclusion

In this meta-analysis of patients with HFpEF, interatrial shunt therapy showed a trend towards an increased risk of HF events and CV mortality compared with the sham procedure, with no significant improvement in MACE, quality of life, or rates of MI and stroke/TIA. These findings raise concerns about interatrial shunt therapy for the broader HFpEF population and highlight the need for better patient selection.

背景：医源性心房分流在保留射血分数（HFpEF）心力衰竭中的临床效果是基于观察数据的，其中压力过载的左心房减压改善了症状和血流动力学。然而，对可能受益的特定患者群体的识别仍不清楚。方法：我们检索了比较HFpEF患者心房分流术和假手术的随机对照试验（rct）。主要研究结果为1例心衰事件和2例心血管（CV）死亡率。结果：纳入3项随机对照试验，共纳入966例患者，其中心房分流组479例（49.5%）。参与者的平均年龄为73.2岁，平均LVEF为58.7%。在接受心房分流安置的479名患者中，69%的患者有运动血流动力学来帮助选择治疗方案。与假手术相比，所选患者的心房分流治疗显示出HF事件（RR:1.29;95%CI:0.98-1.70;p=0.069）和CV死亡（RR:2.30;95%CI:0.94-5.59;p=0.067）增加的趋势。结论：在HFpEF患者的荟萃分析中，与假手术相比，心房分流治疗显示出HF事件和CV死亡率增加的趋势，在MACE、生活质量或MI和卒中/TIA发生率方面没有显著改善。这些发现引起了对心房分流治疗在更广泛的HFpEF人群中的关注，并强调了更好的患者选择的必要性。

{"title":"Interatrial shunt devices in heart failure with preserved ejection fraction: A meta-analysis of randomized trials","authors":"Alonzo Armani Prata , Ana Carolina Covre Coan , Megan Coylewright MD, MPH , Julia Marques Fernandes , Eric Shih Katsuyama MD , Christian Ken Fukunaga , Gabriel Scarpioni Barbosa , Pedro Gabriel Scardini , Gioli-Pereira Luciana MD, PhD","doi":"10.1016/j.cpcardiol.2025.103154","DOIUrl":"10.1016/j.cpcardiol.2025.103154","url":null,"abstract":"<div><h3>Background</h3><div>The clinical effect of an iatrogenic interatrial shunt in heart failure with preserved ejection fraction (HFpEF) was based on observational data, wherein decompression of the pressure-overloaded left atrium improved symptoms and hemodynamics. However, the identification of a specific patient population that may benefit remains unclear.</div></div><div><h3>Methods</h3><div>We searched for randomized controlled trials (RCTs) that compared the creation of interatrial shunts versus a sham procedure in patients with HFpEF. The primary outcomes of interest were HF events and Cardiovascular (CV) mortality.</div></div><div><h3>Results</h3><div>Three RCTs were included, encompassing 966 patients, of which 479 (49.5%) were in the interatrial shunt group. The mean age of the participants was 73.2 years, with an average LVEF of 58.7%. Of the 479 patients undergoing interatrial shunt placement, 69% had exercise hemodynamics to assist in selection for therapy. Interatrial shunt therapy in the selected patients showed a trend towards an increased risk of HF events (RR:1.29;95%CI:0.98-1.70;p=0.069) and CV death (RR:2.30;95%CI:0.94-5.59;p=0.067), compared with the sham procedure.</div></div><div><h3>Conclusion</h3><div>In this meta-analysis of patients with HFpEF, interatrial shunt therapy showed a trend towards an increased risk of HF events and CV mortality compared with the sham procedure, with no significant improvement in MACE, quality of life, or rates of MI and stroke/TIA. These findings raise concerns about interatrial shunt therapy for the broader HFpEF population and highlight the need for better patient selection.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 11","pages":"Article 103154"},"PeriodicalIF":3.3,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Peripartum hypertension and neonatal outcomes across races: 2016-2022 围产期高血压和不同种族新生儿结局：2016-2022

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-20 DOI: 10.1016/j.cpcardiol.2025.103152

Muhammad Shariq Usman MD , Ali Salman MBBS , Eliza Aisha MBBS , Uzair Khan MBBS , Sabina Naz MBBS , Sarah Faisal MBBS , Iqra Yaseen Khan MBBS , Muhammad Hammad Arif MBBS , Neha Mohiuddin MBBS , Ayesha Ali Khan MBBS , Ahson Afzal MBBS , Hamza Janjua MD , Farman Ali MD , Tariq Jamal Siddiqi MD

Background

Maternal hypertension, a major pregnancy complication, can adversely affect newborn health. Our study investigated racial/ethnic disparities in neonatal outcomes among hypertensive pregnant women in the US.

Methods

Using data from the CDC WONDER Natality database, we conducted a retrospective cohort study focusing on live births to hypertensive mothers from 2016 to 2022. We calculated rates [95% CI] per 1000 live births for NICU admissions, neonatal assisted ventilation, low birth weight, and in-hospital mortality across racial/ethnic groups and regions.

Results

We analyzed 2,392,664 live births to hypertensive women. In-hospital neonatal mortality rates were highest in Black American women (BA) (3.6 [3.5, 3.8]). Neonatal assisted ventilation rates were highest in Native Hawaiian/Pacific Islander women (NH/PI) (131.8 [123.4, 140.7]) and low birth weight rates were highest in BA (235.1 [233.9, 236.3]). Across all races, female neonates had a higher rate of low birth weight compared to male neonates, while male neonates had higher incidences of NICU admissions, neonatal assisted ventilation, and in-hospital mortality. The Midwest had the highest rates for NICU admissions in NH/PI (254.2 [217.2, 295.2]), neonatal assisted ventilation in American Indian/Alaska Native women (143.8 [133.2, 155.1]), and in-hospital mortality in BA (4.1 [3.7, 4.5]). The South had the highest rate of low birth weight for BA (244.4 [242.9, 246.0]).

Conclusions

Significant racial and regional disparities exist in neonatal outcomes among hypertensive women in the US, with BA mothers experiencing the poorest outcomes. Further research is necessary to develop targeted interventions for high-risk populations.

背景：孕妇高血压是一种主要的妊娠并发症，可对新生儿健康产生不利影响。我们的研究调查了美国高血压孕妇新生儿结局的种族/民族差异。方法利用美国疾病控制与预防中心WONDER Natality数据库的数据，对2016年至2022年高血压母亲的活产进行回顾性队列研究。我们计算了不同种族/民族和地区新生儿重症监护病房入院率、新生儿辅助通气率、低出生体重率和住院死亡率每1000例活产的95% CI。结果我们分析了2392664例高血压妇女的活产。住院新生儿死亡率最高的是美国黑人妇女（BA）（3.6[3.5, 3.8]）。新生儿辅助通气率最高的是夏威夷原住民/太平洋岛民妇女（NH/PI）（131.8[123.4, 140.7]），低出生体重率最高的是BA（235.1[233.9, 236.3]）。在所有种族中，与男性新生儿相比，女性新生儿的低出生体重率更高，而男性新生儿的NICU入院率、新生儿辅助通气率和住院死亡率更高。中西部地区新生儿重症监护病房住院率最高的是NH/PI(254.2[217.2, 295.2])，新生儿辅助通气的美国印第安/阿拉斯加原住民妇女（143.8 [133.2,155.1]），BA的住院死亡率最高（4.1[3.7,4.5]）。南方地区BA低出生体重率最高（244.4[242.9,246.0]）。结论：美国高血压妇女的新生儿结局存在明显的种族和地区差异，BA母亲的结局最差。需要进一步的研究来制定针对高危人群的有针对性的干预措施。

{"title":"Peripartum hypertension and neonatal outcomes across races: 2016-2022","authors":"Muhammad Shariq Usman MD , Ali Salman MBBS , Eliza Aisha MBBS , Uzair Khan MBBS , Sabina Naz MBBS , Sarah Faisal MBBS , Iqra Yaseen Khan MBBS , Muhammad Hammad Arif MBBS , Neha Mohiuddin MBBS , Ayesha Ali Khan MBBS , Ahson Afzal MBBS , Hamza Janjua MD , Farman Ali MD , Tariq Jamal Siddiqi MD","doi":"10.1016/j.cpcardiol.2025.103152","DOIUrl":"10.1016/j.cpcardiol.2025.103152","url":null,"abstract":"<div><h3>Background</h3><div>Maternal hypertension, a major pregnancy complication, can adversely affect newborn health. Our study investigated racial/ethnic disparities in neonatal outcomes among hypertensive pregnant women in the US.</div></div><div><h3>Methods</h3><div>Using data from the CDC WONDER Natality database, we conducted a retrospective cohort study focusing on live births to hypertensive mothers from 2016 to 2022. We calculated rates [95% CI] per 1000 live births for NICU admissions, neonatal assisted ventilation, low birth weight, and in-hospital mortality across racial/ethnic groups and regions.</div></div><div><h3>Results</h3><div>We analyzed 2,392,664 live births to hypertensive women. In-hospital neonatal mortality rates were highest in Black American women (BA) (3.6 [3.5, 3.8]). Neonatal assisted ventilation rates were highest in Native Hawaiian/Pacific Islander women (NH/PI) (131.8 [123.4, 140.7]) and low birth weight rates were highest in BA (235.1 [233.9, 236.3]). Across all races, female neonates had a higher rate of low birth weight compared to male neonates, while male neonates had higher incidences of NICU admissions, neonatal assisted ventilation, and in-hospital mortality. The Midwest had the highest rates for NICU admissions in NH/PI (254.2 [217.2, 295.2]), neonatal assisted ventilation in American Indian/Alaska Native women (143.8 [133.2, 155.1]), and in-hospital mortality in BA (4.1 [3.7, 4.5]). The South had the highest rate of low birth weight for BA (244.4 [242.9, 246.0]).</div></div><div><h3>Conclusions</h3><div>Significant racial and regional disparities exist in neonatal outcomes among hypertensive women in the US, with BA mothers experiencing the poorest outcomes. Further research is necessary to develop targeted interventions for high-risk populations.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 10","pages":"Article 103152"},"PeriodicalIF":3.3,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144896116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Revisiting type 2 myocardial infarction: Unmet clinical needs 重新审视2型心肌梗死：未满足的临床需求。

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-07 DOI: 10.1016/j.cpcardiol.2025.103148

Andrea Palermi , Silvio Saraullo , Maria Bernadette Giordano , Fabrizio Ricci , Sabina Gallina , Giulia Renda

Cardiovascular disease is the most common cause of mortality and morbidity worldwide and acute coronary syndrome (ACS) is often the first clinical manifestation. Currently, the diagnosis of acute myocardial infarction (AMI) is based on the fourth universal definition of myocardial infarction (MI), with different subtypes based on their pathophysiological background. While type 1 myocardial infarction (T1MI) is defined by an acute coronary event with plaque disruption and consequent athero-thrombosis, type 2 myocardial infarction (T2MI) is defined as an event due to oxygen demand and supply imbalance, unrelated to acute coronary athero-thrombosis. The differentiation between these two entities is crucial since T1MI benefits from an early invasive approach aimed at myocardial reperfusion, while in T2MI it is critical to focus on the cause of the ischemia mismatch. Furthermore, T2MI is often associated with a poorer prognosis. The presence and severity of coronary artery disease (CAD) may significantly influence the ischemic threshold and the risk of T2MI, as it has been identified as an independent predictor of cardiovascular death and recurrent MI. The key point of contention is determining the presence of CAD in T2MI to identify patients eligible for a reperfusion strategy and to tailor therapy as well as secondary prevention strategies.

In this narrative review, we aim to highlight the differences in clinical features, imaging, and biomarkers between T1MI and T2MI, emphasizing the role of CAD, in refining the diagnostic-therapeutic algorithm in T2MI.

心血管疾病是世界范围内最常见的死亡和发病原因，急性冠状动脉综合征（ACS）往往是第一个临床表现。目前，急性心肌梗死（AMI）的诊断是基于心肌梗死（MI）的第四种通用定义，并根据其病理生理背景划分了不同的亚型。1型心肌梗死（T1MI）被定义为急性冠状动脉事件，伴有斑块破裂和随后的动脉粥样硬化血栓形成，而2型心肌梗死（T2MI）被定义为由氧气需求和供应失衡引起的事件，与急性冠状动脉粥样硬化血栓形成无关。区分这两个实体是至关重要的，因为T1MI受益于针对心肌再灌注的早期侵入性方法，而在T2MI中，重点关注缺血失配的原因是至关重要的。此外，T2MI通常与较差的预后相关。冠状动脉疾病（CAD）的存在和严重程度可能会显著影响缺血阈值和T2MI的风险，因为它已被确定为心血管死亡和复发性心肌梗死的独立预测因子。争论的关键点是确定冠心病在T2MI中的存在，以确定适合再灌注策略的患者，并定制治疗和二级预防策略。在这篇叙述性综述中，我们旨在强调T1MI和T2MI在临床特征、影像学和生物标志物方面的差异，强调CAD在完善T2MI诊断治疗算法中的作用。

{"title":"Revisiting type 2 myocardial infarction: Unmet clinical needs","authors":"Andrea Palermi , Silvio Saraullo , Maria Bernadette Giordano , Fabrizio Ricci , Sabina Gallina , Giulia Renda","doi":"10.1016/j.cpcardiol.2025.103148","DOIUrl":"10.1016/j.cpcardiol.2025.103148","url":null,"abstract":"<div><div>Cardiovascular disease is the most common cause of mortality and morbidity worldwide and acute coronary syndrome (ACS) is often the first clinical manifestation. Currently, the diagnosis of acute myocardial infarction (AMI) is based on the fourth universal definition of myocardial infarction (MI), with different subtypes based on their pathophysiological background. While type 1 myocardial infarction (T1MI) is defined by an acute coronary event with plaque disruption and consequent athero-thrombosis, type 2 myocardial infarction (T2MI) is defined as an event due to oxygen demand and supply imbalance, unrelated to acute coronary athero-thrombosis. The differentiation between these two entities is crucial since T1MI benefits from an early invasive approach aimed at myocardial reperfusion, while in T2MI it is critical to focus on the cause of the ischemia mismatch. Furthermore, T2MI is often associated with a poorer prognosis. The presence and severity of coronary artery disease (CAD) may significantly influence the ischemic threshold and the risk of T2MI, as it has been identified as an independent predictor of cardiovascular death and recurrent MI. The key point of contention is determining the presence of CAD in T2MI to identify patients eligible for a reperfusion strategy and to tailor therapy as well as secondary prevention strategies.</div><div>In this narrative review, we aim to highlight the differences in clinical features, imaging, and biomarkers between T1MI and T2MI, emphasizing the role of CAD, in refining the diagnostic-therapeutic algorithm in T2MI.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 10","pages":"Article 103148"},"PeriodicalIF":3.3,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144812628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Electrodes and leads in electrocardiography: a conceptual review 心电图中的电极与导联：概念回顾。

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Current Problems in Cardiology

Pub Date : 2025-08-06 DOI: 10.1016/j.cpcardiol.2025.103150

Mario J. Mc Loughlin MD , Pedro Brugada MD

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Current Problems in Cardiology

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀